Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhanced MAPK signaling is essential for CSF3R-induced leukemia.

Leukemia - 1 Aug 2017

Rohrabaugh S, Kesarwani M, Kincaid Z, Huber E, Leddonne J, Siddiqui Z, Khalifa Y, Komurov K, Grimes H L, Azam M

Abstract excerpt

Both membrane-proximal and truncation mutations in CSF3R have recently been reported to drive the onset of chronic neutrophilic leukemia (CNL). Here we show that although truncation mutation alone cannot induce leukemia, both proximal and compound mutations (proximal and truncation mutations on same allele) are leukemogenic with a disease latency of 90 and 23 days, respectively. Comparative whole-genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Janus Kinase 2
Share to Leukemia
Share to MAP Kinase Kinase 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MAP Kinase Kinase 2

Share to MAP Kinase Signaling System

Share to Pyridones

Share to Pyrimidinones

Share to Receptors, Colony-Stimulating Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 28031554
DOI: 10.1038/leu.2016.376
PMCID: PMC5537052

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhanced MAPK signaling is essential for CSF3R-induced leukemia.PMID 28031554Read ↗

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.Semantic proximity Read ↗

Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategiesSemantic proximity Read ↗

Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor ScreeningSemantic proximity Read ↗

The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.Semantic proximity Read ↗

Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation.Semantic proximity Read ↗

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaSemantic proximity Read ↗

Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemiaSemantic proximity Read ↗

Ligand Independence of the T618I Mutation in the Colony-stimulating Factor 3 Receptor (CSF3R) Protein Results from Loss of O-Linked Glycosylation and Increased Receptor DimerizationSemantic proximity Read ↗

FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferationSemantic proximity Read ↗

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia.Semantic proximity Read ↗

Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia.Semantic proximity Read ↗

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.